2009
DOI: 10.1074/jbc.m808989200
|View full text |Cite
|
Sign up to set email alerts
|

SKI and MEL1 Cooperate to Inhibit Transforming Growth Factor-β Signal in Gastric Cancer Cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
74
0

Year Published

2010
2010
2016
2016

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 80 publications
(77 citation statements)
references
References 45 publications
3
74
0
Order By: Relevance
“…At the transcriptional level, this is best illustrated by EGL-43-and Hamlet-mediated regulation of Notch in invertebrates (Endo et al, 2012;Hwang et al, 2007;Rimann and Hajnal, 2007), and by Prdm3-and Prdm16-mediated regulation of Smad activity in vertebrates (Alliston et al, 2005;Bjork et al, 2010;Izutsu et al, 2001;Sato et al, 2008;Takahata et al, 2009). Because Prdm factors can create global changes in chromatin state, they have interesting potential to construct cell-type-specific chromatin contexts upon which developmental signalling pathways can operate.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…At the transcriptional level, this is best illustrated by EGL-43-and Hamlet-mediated regulation of Notch in invertebrates (Endo et al, 2012;Hwang et al, 2007;Rimann and Hajnal, 2007), and by Prdm3-and Prdm16-mediated regulation of Smad activity in vertebrates (Alliston et al, 2005;Bjork et al, 2010;Izutsu et al, 2001;Sato et al, 2008;Takahata et al, 2009). Because Prdm factors can create global changes in chromatin state, they have interesting potential to construct cell-type-specific chromatin contexts upon which developmental signalling pathways can operate.…”
Section: Discussionmentioning
confidence: 99%
“…Development 139 (13) G9a (Gyory et al, 2004), Lsd1 ), Hdac2 (Yu et al, 2000), Prmt5 (Ancelin et al, 2006) Groucho family (Tle1 and Tle2) (Ren et al, 1999) and Irf4 (Gupta et al, 2001) Prdm2 H3K9 methlytransferase (Kim et al, 2003) p300 (Carling et al, 2004) Prdm2 homodimer (Huang et al, 1998), Rb1 (Buyse et al, 1995) and ER (Medici et al, 1999) Prdm3 p300 (Chakraborty et al, 2001), P/CAF, HDACs (Alliston et al, 2005), SuV39H1 (Cattaneo and Nucifora, 2008), Dnmt3a/b (Senyuk et al, 2011), Mbd3 (Spensberger et al, 2008), Uxt (McGilvray et al, 2007) and PRC (Yoshimi et al, 2011) CtBP (Izutsu et al, 2001;Palmer et al, 2001), Gata1 (Laricchia-Robbio et al, 2006), Jnk (Kurokawa et al, 2000;Spensberger et al, 2008), Runx1 (Senyuk et al, 2007), Smad1/2 (Alliston et al, 2005), Smad3 (Kurokawa et al, 1998) HDACs and p300 (Takahata et al, 2009) Ppar /Ppar , SKI (Takahata et al, 2009), Smad3 (Warner et al, 2007), CtBP , C/EBP ) and Ppargc1 /Ppargc1 (Seale et al, 2007) Bhlhb5, basic helix-loop-helix domain-containing class B5; C/EBP , (CCAAT/enhancer-binding protein ); CtBP, C-terminal binding protein; Dnmt, DNA methyltransferase; ER, oestrogen receptor; Gfi1, growth factor independent 1; HDAC, histone deacetylases; Irf4, interferon regulatory factor 4; Jnk, c-Jun N-terminal kinase; Lsd1, lysinespecific demethylase 1; Mbd3, methyl-CpG binding domain protein 3; Pu.1, SFFV proviral integration 1; P/CAF, p300/CBP-associated factor; Ppar, peroxisomeproliferator-activated receptor; Ppargc1, Ppar co-activator 1 ; Prc, Polycomb repressive complex; Prmt5, protein methyltransferase 5; Rb1, retinoblastoma 1; Runx1, runt-related transcription factor; Smad, MAD homologue; Tle, transducin-like enhancer of split; Uxt, ubiquitously transcribed tetratricopeptide r...…”
Section: Reviewmentioning
confidence: 99%
See 2 more Smart Citations
“…Furthermore, the TGF-␤ inhibitory proteins SKI and SKIL are present in SMAD2/3/4 affinity purifications. These two proteins are known direct interactors of the SMAD2/3/4 complex (19,20). In addition and as expected, we identified the R-SMAD inhibitor LEMD3 (MAN1) (21,22) as a SMAD3 interactor.…”
Section: Gfp-smad Cell Linementioning
confidence: 74%